Desjardins Global Asset Management Inc. Has $581,000 Holdings in Colgate-Palmolive (NYSE:CL)

Desjardins Global Asset Management Inc. trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 25.7% in the fourth quarter, HoldingsChannel reports. The firm owned 7,284 shares of the company’s stock after selling 2,516 shares during the period. Desjardins Global Asset Management Inc.’s holdings in Colgate-Palmolive were worth $581,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CL. OFI Invest Asset Management bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $25,000. Avion Wealth lifted its holdings in Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after buying an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $34,000. Quarry LP raised its position in shares of Colgate-Palmolive by 48.2% during the second quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after acquiring an additional 145 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its stake in shares of Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares in the company, valued at approximately $1,628,484. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 in the last 90 days. 0.34% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. Morgan Stanley upped their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target on the stock. Finally, Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price on the stock in a research note on Monday, January 29th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Stock Up 0.7 %

Colgate-Palmolive stock opened at $86.77 on Thursday. The company has a 50 day moving average of $86.97 and a 200-day moving average of $80.63. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $90.37. The stock has a market capitalization of $71.32 billion, a PE ratio of 31.21, a price-to-earnings-growth ratio of 3.24 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same period last year, the company earned $0.77 earnings per share. Colgate-Palmolive’s quarterly revenue was up 6.9% on a year-over-year basis. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is currently 69.06%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.